Evidence map›Paper›PMID 36100803›Full record

ArticleJournal of molecular histology2022

Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19.

Morteza Gholaminejhad, Mehdi Forouzesh, Babak Ebrahimi, Seyed Amirhosein Mahdavi, Seyed Davood Mirtorabi, Amirreza Liaghat, Seyed Jalil Monabati, Muhammad Obaid Hamza, Gholamreza Hassanzadeh

Open access · bronzeAbstract read
In one paragraph

Article in Journal of molecular histology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Morteza GholaminejhadLegal Medicine Research Center, Legal Medicine Organization, Tehran, Iran.
Mehdi ForouzeshLegal Medicine Research Center, Legal Medicine Organization, Tehran, Iran.
Babak EbrahimiDepartment of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Amirhosein MahdaviLegal Medicine Research Center, Legal Medicine Organization, Tehran, Iran.
Seyed Davood MirtorabiLegal Medicine Research Center, Legal Medicine Organization, Tehran, Iran.
Amirreza LiaghatLegal Medicine Research Center, Legal Medicine Organization, Mashhad, Iran.
Seyed Jalil MonabatiLegal Medicine Research Center, Legal Medicine Organization, Tehran, Iran.
Muhammad Obaid HamzaDepartment of Medical Laboratory Techniques, College of Medical Technical, Al-Farahidi University, Baghdad, Iraq.
Gholamreza HassanzadehLegal Medicine Research Center, Legal Medicine Organization, Tehran, Iran. hassanzadeh@tums.ac.ir.
Iranian Legal Medicine Organization · IRTehran University of Medical Sciences · IRAl-Farahidi University

Funding

Legal Medicine Research Center, Legal Medicine Organization, Tehran, Iran M/99/1083
6 · The paper itself

Abstract

COVID-19 is a contagious disease that attacks many organs but the lungs are the main organs affected. The inflammasome activation results in the exacerbation of inflammatory response in infectious disease. The aim of this study is to investigate the formation and activity of the NLRP3 inflammasome complex and the histopathological changes caused by the coronavirus in the lung of deceased persons with COVID-19. In total, 10 corpses; 5 corpses with no history of any infectious diseases and COVID-19 and 5 corpses with the cause of death of COVID-19 were included in this study. Lung tissue samples were harvested during autopsy under safe conditions. Fresh tissues in each group were used to measure the genes expression and proteins level of NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α and a routine hematoxylin and eosin staining was performed for histological assessment. Data are represented as the means ± SD. Statistical significance difference was accepted at a p-value less than 5%. The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α genes expression and proteins level were elevated in the lung of the COVID-19 group in comparison with the control group. Histological findings presented the increasing number of polymorphonuclear leukocytes, macrophages and also pulmonary fibrosis in the lungs of corpses with the cause of death of COVID-19. High expression of NLRP3 inflammasome components and its relation with the pathophysiology of the coronavirus-infected lung suggested that targeting the NLRP3 inflammasome could be helpful in achieving a more effective treatment in patients with COVID-19.

Indexed as

COVID-19InflammasomesLungCadaverCaspase 1HumansInterleukin-6NLR Family, Pyrin Domain-Containing 3 ProteinTumor Necrosis Factor-alphaCaspase 1InflammasomesInterleukin-6NLR Family, Pyrin Domain-Containing 3 ProteinTumor Necrosis Factor-alphaCoronavirusCOVID-19HistopathologyInflammasomeLungNLRP3

Identifiers

PMID36100803
PMCPMC9470508
OpenAlexW4295751889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.